Intellia Thera CS
(NTLA)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -519,021 | -481,192 | -474,186 | -267,892 | -134,231 |
| Depreciation Amortization | 10,285 | 8,976 | 7,572 | 6,891 | 6,311 |
| Accounts receivable | 27,939 | -32,688 | -1,737 | 99 | 2,490 |
| Accounts payable and accrued liabilities | 6,800 | 2,522 | -4,584 | 529 | 5,060 |
| Other Working Capital | 11,878 | -52,452 | -53,873 | -22,904 | 57,532 |
| Other Operating Activity | 113,239 | 160,748 | 193,521 | 58,247 | 12,926 |
| Operating Cash Flow | $-348,880 | $-394,086 | $-333,287 | $-225,030 | $-49,912 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 131,345 | -17,362 | 218,549 | -535,022 | -210,902 |
| PPE Investments | -5,778 | -13,985 | -13,408 | -12,756 | -3,585 |
| Purchase Of Investment | N/A | N/A | N/A | -3,000 | N/A |
| Other Investing Activity | 0 | 0 | -44,832 | 0 | 0 |
| Investing Cash Flow | $125,567 | $-31,347 | $160,309 | $-550,778 | $-214,487 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 185,747 | 130,323 | 582,955 | 736,688 | 371,779 |
| Financing Cash Flow | $185,747 | $130,323 | $582,955 | $736,688 | $371,779 |
| Beginning Cash Position | 240,353 | 535,463 | 125,486 | 164,606 | 57,226 |
| End Cash Position | 202,787 | 240,353 | 535,463 | 125,486 | 164,606 |
| Net Cash Flow | $-37,566 | $-295,110 | $409,977 | $-39,120 | $107,380 |
| Free Cash Flow | |||||
| Operating Cash Flow | -348,880 | -394,086 | -333,287 | -225,030 | -49,912 |
| Capital Expenditure | -5,778 | -13,985 | -13,558 | -12,756 | -3,585 |
| Free Cash Flow | -354,658 | -408,071 | -346,845 | -237,786 | -53,497 |